PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer have?
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer has 154 citations in the OpenAlex counts ScholarIQ stores.
When was PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer published?
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer has 2018 year in the ScholarIQ index.
What is the open-access status of PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer?
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer has gold oa status in the ScholarIQ index.
What is the DOI of PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer?
The DOI for PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer is on the source record.
What is the PMID of PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer?
The PMID for PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer is on the source record.
What is the OpenAlex record for PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer?
The OpenAlex for PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer is on the source record.